Quick Answer
Arcturus Therapeutics Holdings Inc. reported Shares Outstanding of 28.41 million shares for fiscal year 2025.
Arcturus Therapeutics Holdings Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 28.41M | +5.2% |
| 2024 | 27.00M | +0.6% |
| 2023 | 26.83M | +1.0% |
| 2022 | 26.55M | +0.7% |
| 2021 | 26.37M | +0.7% |
| 2020 | 26.19M | +73.0% |
| 2019 | 15.14M | +41.2% |
| 2018 | 10.72M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 27.23M | +0.6% | +0.3% |
| June 30, 2025 | 27.15M | +0.4% | +0.2% |
| December 31, 2024 | 27.10M | +1.0% | +0.0% |
| September 30, 2024 | 27.08M | +1.4% | +0.2% |
| June 30, 2024 | 27.04M | +1.8% | -0.3% |
| March 31, 2024 | 27.12M | +2.1% | +1.1% |
| December 31, 2023 | 26.83M | +1.0% | +0.4% |
| September 30, 2023 | 26.72M | +0.9% | +0.6% |
- Arcturus Therapeutics Holdings Inc. showed an increase of +5.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Arcturus Therapeutics Holdings Inc.’s shares outstanding has grown by 165.1% (from 10.72 million shares to 28.41 million shares).
- The most recent figure is from Arcturus Therapeutics Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: